SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending with community members discussing its potential trajectory amidst broader crypto market movements. Some traders are anticipating a dump, while others are optimistic about a future pump, possibly fueled by Elon Musk. General sentiment appears mixed as some express concerns about Dogecoin's historical price action.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as investors discuss potential strategic scenarios, including a takeover or a new shipping supercycle driven by global trade shifts. Community discussions revolve around the company's valuation, dividend prospects, and potential for a short squeeze amid rising freight rates and institutional buying. Several analysts are weighing in with divergent views on the outlook.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

Enthusiasm is building around $SLAP, with community members expressing bullish sentiment and highlighting its resilience in the current market. There's a strong sense of camaraderie among holders, who frequently use terms like $WAGMI (we're all gonna make it) and celebrate the project's unique branding and community engagement.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors digest the company's recent earnings, with some highlighting a narrower-than-expected loss and revenue growth. The community is actively discussing the potential impact of Rivian's AI and robotics initiatives, as well as upcoming catalysts like Autonomy Day. Despite some skepticism, optimism is fueled by Amazon's significant stake and hopes for the R2 model's success.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's pursuit of Metsera has intensified, with the company filing a second lawsuit against Novo Nordisk amidst a heated bidding war, driving significant community discussion around the potential acquisition's impact on the competitive landscape of obesity therapeutics. Community members are debating whether Pfizer is overpaying and if the acquisition aligns with their long-term strategy, especially given the existing competition in the weight loss market; at the same time, there's also discussion of Michael Burry's new position in PFE.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

ADUR is trending as the company progresses towards commissioning its pilot plant, aiming to validate its technology for converting waste into valuable resources. Community discussions revolve around the potential of Aduro's technology and its licensing model, with some comparing it favorably to competitors in the clean tech sector. Additionally, the stock's social media presence and marketing efforts are being closely watched.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending amid community discussion around its potential for growth and recent options activity. Some investors express frustration with the stock's recent performance despite analyst ratings, while others remain confident in the long-term vision and potential acquisitions led by Brad Jacobs. The community is actively discussing entry and exit points, with many expressing a bullish outlook.

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Metsera Inc.

Metsera Inc

MTSR is trending due to a bidding war between PFE and NVO to acquire the company and its next-generation obesity pipeline. Community members discuss which company will ultimately win the deal and the potential implications for the broader obesity drug market. Some traders believe a competing bid could still emerge, further driving up the acquisition price.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending amid mixed sentiment, with community members debating whether recent price movements are sustainable or just a "dead cat bounce." Some traders are pointing to potential catalysts like staking rewards and broader crypto market trends, while others warn of a possible downturn and label the token a "sucker coin."

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending due to community discussion around high borrow fees and potential short squeeze, as some retail investors report difficulty lending shares. Traders are debating the impact of dark pool trading and synthetic short positions, suggesting shorts are trapped and retail accumulation is key. Overall, the community is closely watching borrow rates, float size, and potential for a squeeze amid unusual trading activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AGF Management Ltd. Boosts Stock Holdings in Johnson & Johnson $JNJ

AGF Management Ltd. lifted its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 3.5% during the second quarter, according to its most recent 13F filing with the Securities and...

AE Wealth Management LLC Grows Stake in Johnson & Johnson $JNJ

AE Wealth Management LLC increased its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 3.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with...

Johnson & Johnson (NYSE:JNJ) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Johnson & Johnson (NYSE:JNJ - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the twenty-six ratings firms that are covering the stock, MarketBeat...

Best Healthcare Stocks To Consider - November 7th

UnitedHealth Group, Intuitive Surgical, Hims & Hers Health, Globus Medical, Johnson & Johnson, Tempus AI, and Medtronic are the seven Healthcare stocks to watch today, according to MarketBeat's stock...

Johnson & Johnson $JNJ Shares Bought by Harvest Portfolios Group Inc.

Harvest Portfolios Group Inc. grew its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 8.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange...

Validea Detailed Fundamental Analysis - JNJ

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Multi-Factor Investor model based on the published strategy of...

Nvwm LLC Acquires 1,752 Shares of Johnson & Johnson $JNJ

Nvwm LLC increased its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 30.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange...

Ethos Financial Group LLC Decreases Stock Position in Johnson & Johnson $JNJ

Ethos Financial Group LLC trimmed its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 49.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The...

DARZALEX FASPRO is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma

DARZALEX FASPRO is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma DARZALEX FASPRO is the first and only treatment approved by the U.S...

<ul class="summary-bullets"><li>The new approval is the first for the drug under JNJ leadership.&nbsp;</li><li>The drug is also approved for the treatment of bipolar I and II depression as well as schizophrenia in adults.</li><li>JNJ recently submitted a new application for Caplyta to the FDA with data evaluating the safety and efficacy of the medication for the prevention of relapse in schizophrenia. &nbsp;</li></ul>Johnson &amp; Johnson (JNJ) said on Thursday that the U.S. Food and Drug Administration (FDA) has approved its antipsychotic Caplyta in the treatment of major depressive disorder in adults in combination with antidepressants. &nbsp;JNJ gained access to Caplyta with the $14.6 billion acquisition of Intra-Cellular Therapies, Inc., which closed in April. The new approval is the<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.jnj.com/media-center/press-releases/fda-approval-of-caplyta-lumateperone-has-the-potential-to-reset-treatment-expectations-offering-hope-for-remission-in-adults-with-major-depressive-disorder"> first</a> for the drug under JNJ leadership.<h2 class="st-heading-2">The New Approval</h2>Caplyta is also approved for the treatment of bipolar I and II depression as well as schizophrenia in adults.According to the drug maker, major depressive disorder is one of the most common psychiatric disorders, affecting about 22 million American adults. The drug’s new approval is based on results from two late-stage trials where statistically significant and clinically meaningful improvement in depression symptoms were observed when Caplyta was combined with an antidepressant as compared to an oral antidepressant plus placebo.The drug’s safety profile in the studies was consistent with previous studies, and no new safety concerns were identified, it added.JNJ recently submitted a new application for Caplyta to the FDA with data evaluating the safety and efficacy of the medication for the prevention of relapse in schizophrenia. It is also being studied for other neuropsychiatric and neurological disorders. &nbsp;In the third quarter, JNJ reported sales of $240 million from the drug.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/JNJ">JNJ stock</a> stayed within the ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.JNJ stock is up by 28% this year and by about 18% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/uber-in-talks-with-getir-to-expand-delivery-services-in-turkey-report/cL2ttRTRERK">Uber In Talks With Getir To Expand Delivery Services In Turkey: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, a Johnson & Johnson logo seen displayed on a monitor. (Photo Illustration by Valera Golovniov/SOPA Images/LightRocket via Getty Images)

Johnson & Johnson’s Newly Acquired Antipsychotic Drug Approved By FDA For Major Depressive Disorder

JNJ gained access to Caplyta with the $14.6 billion acquisition of Intra-Cellular Therapies, Inc., which closed in April.

Equity

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

JNJ
Johnson & Johnson

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest JNJ News

JNJJohnson & Johnson